IRulya Therapeutics Inc. (IRLA) stock
IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$38.45+1.09 (+2.92%)
Close on Nov 17, 2026Market cap $39.11MP/E –Yield –
IRulya Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
IRulya Therapeutics's market cap was $38.98M on Nov 11, 2026, against $3.98B a year earlier. Over the last 5 years it ranged from $5.57M to $7.54B, with a median of $951.79M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $38.98M | -98.9% |
| 2025 | Dec 31, 2025 | $3.65B | +125.6% |
| 2024 | Dec 31, 2024 | $1.62B | +112.1% |
| 2023 | Dec 29, 2023 | $763.22M | +65.7% |
| 2022 | Dec 30, 2022 | $460.59M | -93.9% |
| 2021 | Dec 31, 2021 | $7.54B | -54.0% |
| 2020 | Dec 31, 2020 | $16.39B | -45.6% |
| 2019 | Dec 31, 2019 | $30.14B | – |
See a number that looks wrong?